Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA342283
Max Phase: Preclinical
Molecular Formula: C15H22N6O4S
Molecular Weight: 382.45
Molecule Type: Small molecule
Associated Items:
ID: ALA342283
Max Phase: Preclinical
Molecular Formula: C15H22N6O4S
Molecular Weight: 382.45
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: Nc1ncnc2c1ncn2C1CC(CSCCC(N)C(=O)O)C(O)C1O
Standard InChI: InChI=1S/C15H22N6O4S/c16-8(15(24)25)1-2-26-4-7-3-9(12(23)11(7)22)21-6-20-10-13(17)18-5-19-14(10)21/h5-9,11-12,22-23H,1-4,16H2,(H,24,25)(H2,17,18,19)
Standard InChI Key: MZBVTOOFTWJQRK-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 382.45 | Molecular Weight (Monoisotopic): 382.1423 | AlogP: -0.77 | #Rotatable Bonds: 7 |
Polar Surface Area: 173.40 | Molecular Species: ZWITTERION | HBA: 10 | HBD: 5 |
#RO5 Violations: 0 | HBA (Lipinski): 10 | HBD (Lipinski): 7 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: 2.01 | CX Basic pKa: 9.50 | CX LogP: -3.91 | CX LogD: -3.91 |
Aromatic Rings: 2 | Heavy Atoms: 26 | QED Weighted: 0.38 | Np Likeness Score: 0.67 |
1. Houston DM, Matuszewska B, Borchardt RT.. (1985) Potential inhibitors of S-adenosylmethionine-dependent methyltransferases. 10. Base- and amino acid modified analogues of S-aristeromycinyl-L-homocysteine., 28 (4): [PMID:3981540] [10.1021/jm00382a016] |
2. Houston DM, Matuszewska B, Borchardt RT.. (1985) Potential inhibitors of S-adenosylmethionine-dependent methyltransferases. 10. Base- and amino acid modified analogues of S-aristeromycinyl-L-homocysteine., 28 (4): [PMID:3981540] [10.1021/jm00382a016] |
3. Houston DM, Matuszewska B, Borchardt RT.. (1985) Potential inhibitors of S-adenosylmethionine-dependent methyltransferases. 10. Base- and amino acid modified analogues of S-aristeromycinyl-L-homocysteine., 28 (4): [PMID:3981540] [10.1021/jm00382a016] |
Source(1):